- Home
- ASRT vs MNOV Comparison
ASRT vs MNOV Comparison
Compare ASRT & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ASRT | MNOV |
|---|---|---|
| Founded | 1995 | 2000 |
| Country | US | US |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 76.0M | 72.7M |
| IPO Year | 2004 | 2004 |
Fundamental Metrics
Financial Performance| Metric | ASRT | MNOV |
|---|---|---|
| Price | $11.82 | $1.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $35.00 | $7.00 |
| AVG Volume (30 Days) | 38.9K | ★ 66.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 95.07 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $124,961,000.00 | $2,360,807.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.42 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 194.15 |
| 52 Week Low | $0.51 | $1.13 |
| 52 Week High | $12.95 | $1.96 |
Technical Indicators
Market Signals| Indicator | ASRT | MNOV |
|---|---|---|
| Relative Strength Index (RSI) | 60.85 | 47.78 |
| Support Level | $11.56 | $1.47 |
| Resistance Level | $12.53 | $1.69 |
| Average True Range (ATR) | 0.65 | 0.09 |
| MACD | -0.29 | -0.02 |
| Stochastic Oscillator | 35.62 | 27.78 |
Price Performance
Historical ComparisonAbout ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's strategies are to focus its developing activities on therapeutics for neurological disorders and fibrotic diseases.